» Articles » PMID: 34965177

A Case of V180I Genetic Mutation Creutzfeldt Jakob Disease (CJD) with Delusional Misidentification As an Initial Symptom

Overview
Journal Prion
Specialty Biochemistry
Date 2021 Dec 29
PMID 34965177
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

An 84-year-old woman who had been diagnosed as having dementia with Lewy body (DLB) upon initial examination exhibited cognitive impairments and person delusional misidentification (DMS): she transiently claimed that her spouse was a stranger. She was re-examined at the age of 89 years; her frequency of speech and activities of daily living had both decreased, leading to verbal communication difficulties complicated by sensory aphasia, and brain diffusion-weighted (DW) magnetic resonance imaging (MRI) showed cortical hyperintensities in some areas of both hemispheres. About 4 months later, the DW high-intensity areas were observed to have expanded into diffuse cortical areas. While the clinical features of Creutzfeldt Jakob disease (CJD) (myoclonus; ataxia; parkinsonism; rapidly progressive cognitive impairments; periodic sharp discharges on electroencephalograms) were not observed, a genetic analysis of the prion protein () gene, which was performed because of a family history of dementia, revealed a V180I mutation (heterozygosis: valine/isoleucine) suggesting genetic CJD (g-CJD). Her activity progressively decreased, reaching akinetic mutism about 11 months after the re-examination. Finally, she suffered from severe bedsores and died from aspiration pneumonia at the age of 90 years. The present report describes the first case of person DMS as an initial neuropsychiatric symptom for V180I g-CJD; the typical long-term clinical symptoms of CJD were not observed in this patient. The inclusion of person DMS as an initial clinical symptom and the presence of expansive cortical hyperintensity areas may be useful for clinicians attempting to diagnosis V180I g-CJD in patients with elusive symptoms.

Citing Articles

Addressing the Unmet Needs of Patients With Rapidly Progressive Neurological Disease: A Case Report of Palliative Care in Creutzfeldt-Jakob Disease (CJD).

Price J, Kheirbek R Cureus. 2024; 16(2):e55228.

PMID: 38558630 PMC: 10981389. DOI: 10.7759/cureus.55228.


Prion Mutations in Republic of Republic of Korea, China, and Japan.

Kim D, Shim K, Bagyinszky E, An S Int J Mol Sci. 2023; 24(1).

PMID: 36614069 PMC: 9820783. DOI: 10.3390/ijms24010625.


Systematic Review of Clinical and Pathophysiological Features of Genetic Creutzfeldt-Jakob Disease Caused by a Val-to-Ile Mutation at Codon 180 in the Prion Protein Gene.

Matsubayashi T, Sanjo N Int J Mol Sci. 2022; 23(23).

PMID: 36499498 PMC: 9737045. DOI: 10.3390/ijms232315172.


Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer's Disease.

Nagata T, Shinagawa S, Inamura K, Shigeta M J Pers Med. 2022; 12(9).

PMID: 36143150 PMC: 9501542. DOI: 10.3390/jpm12091365.

References
1.
McKeith I, Boeve B, Dickson D, Halliday G, Taylor J, Weintraub D . Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology. 2017; 89(1):88-100. PMC: 5496518. DOI: 10.1212/WNL.0000000000004058. View

2.
Hudson A, Grace G . Misidentification syndromes related to face specific area in the fusiform gyrus. J Neurol Neurosurg Psychiatry. 2000; 69(5):645-8. PMC: 1763428. DOI: 10.1136/jnnp.69.5.645. View

3.
Solvason H, Harris B, Zeifert P, Flores B, Hayward C . Psychological versus biological clinical interpretation: a patient with prion disease. Am J Psychiatry. 2002; 159(4):528-37. DOI: 10.1176/appi.ajp.159.4.528. View

4.
Devanand D, Jacobs D, Tang M, Sano M, Marder K, Bell K . The course of psychopathologic features in mild to moderate Alzheimer disease. Arch Gen Psychiatry. 1997; 54(3):257-63. DOI: 10.1001/archpsyc.1997.01830150083012. View

5.
Tomizawa Y, Taniguchi D, Furukawa Y . Genetic Creutzfeldt-Jakob disease mimicking dementia with Lewy bodies: Clinical and radiological findings. J Neurol Sci. 2019; 409:116604. DOI: 10.1016/j.jns.2019.116604. View